Home » Topics » Patents, BioWorld Science

Patents, BioWorld Science
RSS

Antibacterial oxazolidinones claimed by Pfizer

Dec. 1, 2004

Novartis researchers describe beta2-adrenergic agonists

Dec. 1, 2004

Novel MAP kinase/TNF inhibitors in early development at Pfizer

Dec. 1, 2004

Dual acting compounds for the treatment of psychiatric disorders

Dec. 1, 2004

A series of protein tyrosine phosphatase inhibitors described in a patent

Dec. 1, 2004

Merck claims a series of CGRP receptor antagonists

Dec. 1, 2004

GABA-A receptor modulators described by NeuroSearch

Dec. 1, 2004

New compounds for the treatment of psychiatric and mood disorders

Dec. 1, 2004

Sankyo researchers prepare and test PTP inhibitors

Nov. 30, 2004

Agents for the treatment of arthritis claimed by Sumitomo

Nov. 30, 2004

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 29, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 29, 2025.
Researchers discover how glioblastoma tumors dodge chemotherapy
BioWorld MedTech
Researchers at the University of Sydney have uncovered a mechanism that may explain why glioblastoma returns after treatment, and the world-first discovery offers...
Shionogi nabs revenue-generating ALS drugs with $2.5B Tanabe pact
BioWorld
Shionogi & Co. Ltd. will acquire global rights to U.S. FDA approved amyotrophic lateral sclerosis therapy edaravone through a $2.5 billion acquisition deal with...
Big pharma taps fast Asia innovation in search of next Keytruda
BioWorld
Speed and innovation from Asia Pacific’s (APAC) biotechnology sector had big pharma scouring the region for the next oncology heir to Keytruda (pembrolizumab),...